Logo-jpe
J Prev Epidemiol. 2019;4(1): e08.
  Abstract View: 2176
  PDF Download: 1576

Epidemiology and Prevention

Antioxidant therapy to improve cisplatin nephrotoxicity  

Niloufar Hooshyar 1 ORCID logo, Banafsheh Yalameha 2 ORCID logo, Mehrnoosh Sedighi 3 ORCID logo, Mohammadreza Khosravifarsani 4* ORCID logo, Parto Nasri 5 ORCID logo

1 Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
2 Department of Biochemistry, Faculty of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran
3 Cardiovascular Research Center, Shahid Rahimi Hospital, Lorestan University of Medical Sciences, Khoramabad, Iran
4 Cancer Prevention Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
5 Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
*Corresponding Author: Correspondence to: Mohammadreza Khosravifarsani, Email: , Email: drmohammadkhf@gmail.com

Citation: Hooshyar N, Yalameha B, Sedighi M, Khosravifarsani M, Nasri P. Antioxidant therapy to improve cisplatin nephrotoxicity. J Prev Epidemiol. 2019;4(1):e08.  
First Name
Last Name
Email Address
Comments
Security code


Abstract View:

Your browser does not support the canvas element.

PDF Download:

Your browser does not support the canvas element.


Full Text View:

Your browser does not support the canvas element.